Article: FDA Approval of Over-The-Counter -OTC- Claritin has Profound Bottom Line Implications for Health Plans, According to Medco Health Solutions.

Business Editors

FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--Nov. 27, 2002

Medco Health Expects to Help Save Health Plans and Employers

Up to $500 Million Based on OTC Blockbuster Availability

The approval today by the Food and Drug Administration (FDA) allowing marketing of the non-sedating antihistamine Claritin for over-the-counter (OTC) use provides a tremendous opportunity for health plans and employers to save millions of dollars in drug spend, according to Medco Health Solutions, Inc., the nation's leading pharmacy benefits manager.

This year Medco Health clients, who include approximately 200 of Fortune's Top 500 companies, ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!